No connection

Search Results

BCPC

NEUTRAL
$167.54 Live
Balchem Corporation · NASDAQ
Target $191.0 (+14.0%)
$139.17 52W Range $177.4

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$5.44B
P/E
36.74
ROE
12.1%
Profit margin
14.7%
Debt/Equity
0.13
Dividend yield
0.57%

AI Analysis

AI-powered fundamental assessment

Confidence
78%
Balchem Corporation exhibits strong financial health with a Piotroski F-Score of 8/9, indicating robust fundamentals and operational efficiency. Despite this, the stock trades at a premium valuation (P/E 36.74 vs sector avg 29.27) above both the Graham Number ($64.13) and intrinsic value estimate ($134.52), raising concerns about overvaluation. While earnings and revenue growth are solid (20.4% YoY EPS, 11.5% revenue), insider selling activity and a bearish technical trend signal caution. The company's low debt (D/E 0.13) and consistent earnings beat history support stability, but stretched valuations limit near-term upside potential.

Key Strengths

Exceptional financial health with Piotroski F-Score of 8/9, reflecting strong profitability, leverage control, and operating efficiency
Low leverage and strong liquidity: Debt/Equity of 0.13, Current Ratio of 2.72, and Quick Ratio of 1.56 indicate minimal solvency risk
Consistent earnings growth: 20.4% YoY earnings growth and a 19.5% YoY EPS increase, with 22 out of 25 quarters beating estimates
High profitability margins: 14.72% net margin and 20.40% operating margin exceed sector averages significantly
Analyst consensus supports upside: Average target price of $191.00 implies ~14% upside from current levels

Key Risks

Elevated valuation: Current price of $167.54 trades at a significant premium to Graham Number ($64.13) and intrinsic value ($134.52)
Rich P/E multiple: Forward P/E of 30.06 and trailing P/E of 36.74 are above sector average (29.27), increasing sensitivity to growth misses
Bearish insider activity: Net insider selling of $2.34M over last 6 months suggests lack of confidence among executives/directors
Weak technical trend: Technical Trend score of 0/100 indicates deteriorating price momentum and potential near-term downside
Dividend unattractiveness: Low yield of 0.57% and weak Dividend Strength score (25/100) limits appeal for income investors
AI Fair Value Estimate
Based on comprehensive analysis
$134.52
-19.7% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
64
Strong
Value
45
Future
75
Past
80
Health
90
Dividend
30
AI Verdict
Moderately bullish on fundamentals, but constrained by valuation and technicals
Key drivers: High Piotroski F-Score, Strong earnings growth, Low debt profile, Rich valuation multiples, Bearish insider and technical signals
Confidence
82%
Value
45/100

Ref P/E, PEG, Graham Number

Positives
  • Below intrinsic value estimate based on growth metrics ($134.52)
Watchpoints
  • Current price ($167.54) significantly above Graham Number ($64.13)
  • P/E of 36.74 and Price/Book of 4.18 indicate premium valuation
Future
75/100

Ref Growth rates

Positives
  • 20.4% YoY earnings growth
  • 11.5% revenue growth
  • Q/Q earnings growth of 19.1%
Watchpoints
No urgent risks highlighted.
Past
80/100

Ref Historical trends

Positives
  • 22 out of 25 quarters beat EPS estimates
  • Consistent positive earnings surprises since 2020
  • Long-term revenue and earnings progression upward
Watchpoints
No urgent risks highlighted.
Health
90/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score of 8/9 indicates excellent financial health
  • Debt/Equity ratio of 0.13 shows minimal leverage
  • Current and Quick Ratios well above 1.0
Watchpoints
  • Altman Z-Score not available limits full distress risk assessment
Dividend
30/100

Ref Yield, Payout

Positives
  • Low payout ratio of 19.04% provides sustainability
Watchpoints
  • Dividend Strength score of 25/100
  • Yield of 0.57% is below market average
  • No 5-year yield average available suggests limited history or consistency

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$167.54
Analyst Target
$191.0
Upside/Downside
+14.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BCPC and closest competitors.

Updated 2026-01-23
BCP
Balchem Corporation
Primary
5Y
+45.9%
3Y
+30.9%
1Y
+3.9%
6M
+13.3%
1M
+6.7%
1W
-0.7%
UFP
UFP Industries, Inc.
Peer
5Y
+29.6%
3Y
+24.0%
1Y
-5.3%
6M
+3.9%
1M
+7.6%
1W
+0.1%
CLF
Cleveland-Cliffs Inc.
Peer
5Y
-48.4%
3Y
-36.1%
1Y
+23.4%
6M
-25.7%
1M
+14.3%
1W
-1.8%
AUG
Aura Minerals Inc.
Peer
5Y
+185.0%
3Y
+185.0%
1Y
+185.0%
6M
+173.8%
1M
+31.9%
1W
+13.4%
MEO
Methanex Corporation
Peer
5Y
+66.5%
3Y
+38.8%
1Y
+123.6%
6M
+61.9%
1M
+15.9%
1W
-3.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
36.74
Forward P/E
30.06
PEG Ratio
N/A
P/B Ratio
4.18
P/S Ratio
5.36
EV/Revenue
5.46
EV/EBITDA
22.16
Market Cap
$5.44B

Profitability

Profit margins and return metrics

Profit Margin 14.72%
Operating Margin 20.4%
Gross Margin 35.82%
ROE 12.06%
ROA 7.87%

Growth

Revenue and earnings growth rates

Revenue Growth +11.5%
Earnings Growth +20.4%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +19.1%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.13
Low debt
Current Ratio
2.72
Strong
Quick Ratio
1.56
Excellent
Cash/Share
$2.01

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-20
$N/A
2025-10-21
$1.35
+3.0% surprise
2025-07-31
$1.27
+1.6% surprise
2025-04-24
$1.22
+0.4% surprise

Basic Materials Sector Comparison

Comparing BCPC against 143 companies in the Basic Materials sector (14 bullish, 54 neutral, 75 bearish)
P/E Ratio
36.74
This Stock
vs
38.86
Sector Avg
-5.5% (Discount)
Return on Equity (ROE)
12.06%
This Stock
vs
-6.64%
Sector Avg
-281.6% (Below Avg)
Profit Margin
14.72%
This Stock
vs
-5.75%
Sector Avg
-355.9% (Weaker)
Debt to Equity
0.13
This Stock
vs
0.89
Sector Avg
-85.1% (Less Debt)
Revenue Growth
11.5%
This Stock
vs
36.56%
Sector Avg
-68.5% (Slower)
Current Ratio
2.72
This Stock
vs
5.16
Sector Avg
-47.3% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

VAN GUNSTEREN JOB LEONARD
Officer
Option Exercise
2025-12-04
6,000 shares · $365,100
VAN GUNSTEREN JOB LEONARD
Officer
Sell
2025-12-04
6,000 shares · $919,723
FISCHER DAVID B
Director
Option Exercise
2025-12-03
6,000 shares · $472,334
FISCHER DAVID B
Director
Sell
2025-12-03
8,000 shares · $1,231,748
REID MARTIN LUTHER
Officer
Sell
2025-11-11
1,200 shares · $185,328
GRAHAM GEORGE
Officer
Stock Award
2025-10-20
2,500 shares
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
4 analysts
Rothschild & Co
2025-12-05
init
Neutral
HC Wainwright & Co.
2025-10-22
Maintains
Buy Buy
HC Wainwright & Co.
2025-08-04
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning BCPC from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile